Total Payments
$865,298
2024 Payments
$248,336
Companies
15
Transactions
617
Medicare Patients
1,370
Medicare Billing
$202,868
Payment Breakdown by Category
Other$692,159 (80.0%)
Consulting$87,075 (10.1%)
Travel$70,661 (8.2%)
Food & Beverage$14,231 (1.6%)
Education$1,172 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $592,321 | 171 | 68.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $99,838 | 26 | 11.5% |
| Consulting Fee | $87,075 | 29 | 10.1% |
| Travel and Lodging | $70,661 | 215 | 8.2% |
| Food and Beverage | $14,231 | 174 | 1.6% |
| Education | $1,172 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $252,948 | 146 | $0 (2024) |
| Eisai Inc. | $251,923 | 127 | $0 (2024) |
| TESARO, Inc. | $201,587 | 208 | $0 (2019) |
| ABBVIE INC. | $74,188 | 34 | $0 (2024) |
| Merck Sharp & Dohme LLC | $57,471 | 59 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $13,201 | 14 | $0 (2024) |
| ImmunoGen, Inc. | $12,001 | 9 | $0 (2024) |
| Intuitive Surgical, Inc. | $1,571 | 8 | $0 (2019) |
| Siemens Medical Solutions USA, Inc. | $132.16 | 1 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $93.40 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $248,336 | 115 | Eisai Inc. ($112,079) |
| 2023 | $162,184 | 91 | Eisai Inc. ($88,311) |
| 2022 | $147,480 | 88 | GlaxoSmithKline, LLC. ($113,177) |
| 2021 | $37,774 | 37 | Eisai Inc. ($28,723) |
| 2020 | $57,675 | 57 | Merck Sharp & Dohme Corporation ($27,394) |
| 2019 | $142,972 | 161 | TESARO, Inc. ($132,723) |
| 2018 | $68,876 | 68 | TESARO, Inc. ($68,864) |
All Payment Transactions
617 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 12/20/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $121.81 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $1,133.13 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2024 | Eisai Inc. | Lenvima (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $815.00 | General |
| Category: Oncology | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | ELAHERE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,654.00 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Travel and Lodging | In-kind items and services | $451.16 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $120.14 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | ELAHERE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,254.00 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,460.00 | General |
| Category: Oncology | ||||||
| 11/04/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $241.40 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $110.74 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $28.99 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,800.00 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | ELAHERE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,254.00 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | ELAHERE (Drug) | Travel and Lodging | In-kind items and services | $864.46 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Oncology | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | In-kind items and services | $421.20 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | In-kind items and services | $1,194.34 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Travel and Lodging | In-kind items and services | $374.71 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 312 | 426 | $81,018 | $34,283 |
| 2022 | 8 | 361 | 509 | $175,714 | $60,853 |
| 2021 | 8 | 341 | 522 | $164,304 | $59,555 |
| 2020 | 6 | 356 | 533 | $150,649 | $48,178 |
Total Patients
1,370
Total Services
1,990
Medicare Billing
$202,868
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 77 | 119 | $26,299 | $12,298 | 46.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 97 | 124 | $17,484 | $8,296 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 40 | 64 | $14,144 | $5,197 | 36.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $9,909 | $3,726 | 37.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 45 | 57 | $8,037 | $2,986 | 37.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 26 | 35 | $5,145 | $1,780 | 34.6% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 21 | 21 | $65,037 | $16,852 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 143 | $31,603 | $14,078 | 44.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 87 | $12,267 | $6,033 | 49.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 39 | 71 | $15,691 | $5,539 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $12,478 | $4,395 | 35.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 15 | 27 | $8,640 | $3,233 | 37.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 22 | $7,040 | $3,168 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 40 | 53 | $7,473 | $2,974 | 39.8% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2022 | 16 | 16 | $8,750 | $2,192 | 25.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 15 | $3,795 | $1,309 | 34.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2022 | 16 | 20 | $2,940 | $1,081 | 36.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 96 | 162 | $35,802 | $16,483 | 46.0% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 15 | 16 | $49,552 | $12,063 | 24.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 53 | 95 | $20,995 | $7,719 | 36.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 20 | 34 | $10,880 | $5,324 | 48.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 54 | 64 | $9,024 | $4,193 | 46.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 18 | 32 | $10,240 | $3,775 | 36.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $6,973 | $2,596 | 37.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 11 | 11 | $5,115 | $2,116 | 41.4% |
About Dr. Amina Ahmed, MD
Dr. Amina Ahmed, MD is a Gynecologic Oncology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154372068.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amina Ahmed, MD has received a total of $865,298 in payments from pharmaceutical and medical device companies, with $248,336 received in 2024. These payments were reported across 617 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($592,321).
As a Medicare-enrolled provider, Ahmed has provided services to 1,370 Medicare beneficiaries, totaling 1,990 services with total Medicare billing of $202,868. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology, Obstetrics & Gynecology
- Location Chicago, IL
- Active Since 05/15/2006
- Last Updated 03/04/2020
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1154372068
Products in Payments
- ZEJULA (Drug) $357,615
- Lenvima (Drug) $251,632
- JEMPERLI (Biological) $88,495
- ELAHERE (Drug) $75,942
- KEYTRUDA (Biological) $52,047
- LYNPARZA (Drug) $12,783
- Elahere (Biological) $10,247
- Da Vinci Surgical System (Device) $1,571
- ACUSON SC2000 Diagnostic Ultrasound System (Device) $132.16
- Ultrasound Probes (Device) $71.58
- PRADAXA (Drug) $71.24
- Tempus Pixel (Device) $70.91
- JARDIANCE (Drug) $22.16
- OCREVUS (Biological) $14.29
- Balcoltra (Drug) $13.53
- WATCHMAN (Device) $12.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Chicago
Dario Roque, Md, MD
Gynecologic Oncology — Payments: $449,686
Gynecologic Oncology $449,686
Dr. Jenna Marcus, M.d, M.D
Gynecologic Oncology — Payments: $195,339
Gynecologic Oncology $195,339
Dr. Summer Dewdney, M.d, M.D
Gynecologic Oncology — Payments: $55,875
Gynecologic Oncology $55,875
Emily Hinchcliff, M.d, M.D
Gynecologic Oncology — Payments: $31,049
Gynecologic Oncology $31,049
Wilberto Nieves Neira, Md, MD
Gynecologic Oncology — Payments: $20,077
Gynecologic Oncology $20,077
Kathryn Mills
Gynecologic Oncology — Payments: $19,680
Gynecologic Oncology $19,680